Skip to content

Zymeworks ZYME Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Operating margin-87.3%+92.3pp-179.7%+1.9pp-181.6%-213pp31.6%
Net margin-76.6%+84.2pp-160.8%-4.7pp-156.1%-186pp30.1%
Returns
Return on equity-26.7%+3.8pp-30.5%-5.8pp-24.8%-58.3pp33.5%+97.8pp
Return on invested capital-34.5%+9.4pp-43.9%+16.9pp-60.8%-181pp120.1%
Efficiency
Asset turnover0.3×+0.1×0.1×0.0×0.1×-0.7×0.8×
Liquidity
Current ratio5.9×+2.5×3.4×-4.0×7.4×+1.7×5.7×+1.7×
Leverage
Debt-to-equity0.1×0.0×0.1×0.0×0.1×0.0×0.1×-0.1×
Per Share
Book value per share$3.56-20.3%$4.46-33.9%$6.75-10.7%$7.56+58.1%
Valuation
Market capitalization$1.99B+96.9%$1.01B+85.7%$543.09M+9.7%$495.15M-35.1%
Price / sales18.7×+5.5×13.2×+6.1×7.1×+5.9×1.2×
Price / book7.4×+4.4×+1.8×1.2×+0.2×-2.1×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Zymeworks's ratios come from?
Every ratio is computed from Zymeworks's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.